About PPAJX
The GMO U.S. Opportunistic Value Fund R6 is a large value mutual fund designed to generate total return primarily through investments in U.S. equities. Guided by GMO's Asset Allocation and Systematic Equity teams, this fund targets the most undervalued segments of the U.S. stock market, concentrating on "deep value" stocks—typically those in the cheapest 20% when measured against their historical valuations—while deliberately avoiding "shallow value" equities that may appear inexpensive by some metrics but are relatively expensive based on their own history. Its investment strategy emphasizes rigorous fundamental analysis and top-down market insights, with the portfolio measuring performance against the MSCI U.S. Value Index. The fund is notably diversified, holding over 160 securities across sectors such as financial services, healthcare, energy, communication services, and technology. Top holdings include prominent companies like Alphabet, JPMorgan Chase, Johnson & Johnson, Meta Platforms, and Exxon Mobil. By focusing on attractively priced equities, the fund seeks to capitalize on value opportunities often overlooked by broader market benchmarks, serving institutional and retirement investors seeking a disciplined, value-oriented approach to U.S. equities.
Fund Family GMO
Category Large Value
Performance Rating Average
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol PPAJX
Share Class Class R6
Index MSCI USA Value TR USD
PPAJX had a total return of 22.42% in the past year, including dividends.
Since the fund's inception, the average annual return has been 20.42%.
